Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan

Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan

Background & aims: Treatment of hepatitis C virus (HCV) by elbasvir/grazoprevir (EBR/GZR) was found to be efficacious and well tolerated in clinical trials. This study aimed to evaluate the effectiveness and tolerability of EBR/GZR in the treatment of HCV genotype 1-infected Taiwanese patien...

Full description

Bibliographic Details
Main Authors: Pin-Nan Cheng, Chi-Yi Chen, Ming-Lung Yu, Chun-Che Lin, Chun-Yen Lin, Cheng-Yuan Peng, Kuo-Chih Tseng, Ching-Chu Lo, I-Hao Tseng, Chun-Jen Liu
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
EBR/GZR
HCV
Genotype 1
Effectiveness
Tolerability
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118220301183

Internet

http://www.sciencedirect.com/science/article/pii/S1684118220301183

Similar Items